These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 21144344)
1. Patch testing with methyldibromoglutaronitrile in a localized population in the United States. Javvaji S; Belsito DV Dermatitis; 2010; 21(6):321-6. PubMed ID: 21144344 [TBL] [Abstract][Full Text] [Related]
2. Methyldibromoglutaronitrile (Euxyl K400): a new and important sensitizer in the United States? Jackson JM; Fowler JF J Am Acad Dermatol; 1998 Jun; 38(6 Pt 1):934-7. PubMed ID: 9632000 [TBL] [Abstract][Full Text] [Related]
3. Positive patch-test reactions to iodopropynyl butylcarbamate: retrospective analysis of North American contact dermatitis group data, from 1998 to 2008. Warshaw EM; Boralessa Ratnayake D; Maibach HI; Sasseville D; Belsito DV; Zug KA; Fowler JF; Taylor JS; Toby Mathias CG; Fransway AF; Deleo VA; Marks JG; Storrs FJ; Pratt MD; Rietschel RL Dermatitis; 2010; 21(6):303-10. PubMed ID: 21144341 [TBL] [Abstract][Full Text] [Related]
9. Methyldibromoglutaronitrile is an important contact allergen in The Netherlands. de Groot AC; de Cock PA; Coenraads PJ; van Ginkel CJ; Jagtman BA; van Joost T; Joost van der Kley AM; Meinardi MM; Smeenk G; van der Valk PG; van der Walle HB; Weyland JW Contact Dermatitis; 1996 Feb; 34(2):118-20. PubMed ID: 8681539 [TBL] [Abstract][Full Text] [Related]
10. Recommendation to include methyldibromo glutaronitrile in the European standard patch test series. Bruze M; Goossens A; Gruvberger B; ; Contact Dermatitis; 2005 Jan; 52(1):24-8. PubMed ID: 15701126 [TBL] [Abstract][Full Text] [Related]
11. Provocative use testing of methyldibromo glutaronitrile in a cosmetic shampoo. Tosti A; Vincenzi C; Smith KA Contact Dermatitis; 2000 Feb; 42(2):64-7. PubMed ID: 10703625 [TBL] [Abstract][Full Text] [Related]
12. Contact allergy in children referred for patch testing: North American Contact Dermatitis Group data, 2001-2004. Zug KA; McGinley-Smith D; Warshaw EM; Taylor JS; Rietschel RL; Maibach HI; Belsito DV; Fowler JF; Storrs FJ; DeLeo VA; Marks JG; Mathias CG; Pratt MD; Sasseville D Arch Dermatol; 2008 Oct; 144(10):1329-36. PubMed ID: 18936397 [TBL] [Abstract][Full Text] [Related]
13. Patch testing with methyldibromoglutaronitrile. Geier J; Schnuch A; Brasch J; Gefeller O Am J Contact Dermat; 2000 Dec; 11(4):207-12. PubMed ID: 11123412 [TBL] [Abstract][Full Text] [Related]
14. Patch-test results of the North American Contact Dermatitis Group 2005-2006. Zug KA; Warshaw EM; Fowler JF; Maibach HI; Belsito DL; Pratt MD; Sasseville D; Storrs FJ; Taylor JS; Mathias CG; Deleo VA; Rietschel RL; Marks J Dermatitis; 2009; 20(3):149-60. PubMed ID: 19470301 [TBL] [Abstract][Full Text] [Related]
15. Iodopropynylbutyl carbamate 0.2% is suggested for patch testing of patients with eczema possibly related to preservatives. Brasch J; Schnuch A; Geier J; Aberer W; Uter W; ; Br J Dermatol; 2004 Sep; 151(3):608-15. PubMed ID: 15377347 [TBL] [Abstract][Full Text] [Related]
16. Eyelid dermatitis in patients referred for patch testing: Retrospective analysis of North American Contact Dermatitis Group data, 1994-2016. Warshaw EM; Voller LM; Maibach HI; Zug KA; DeKoven JG; Atwater AR; Reeder MJ; Sasseville D; Taylor JS; Fowler JF; Pratt MD; Silverberg JI; Fransway AF; Zirwas MJ; Belsito DV; Marks JG; DeLeo VA J Am Acad Dermatol; 2021 Apr; 84(4):953-964. PubMed ID: 32679276 [TBL] [Abstract][Full Text] [Related]